HT
SIOX

HAP Trading’s Sio Gene Therapies Inc. Common Stock SIOX Stock Holding History

HAP Trading’s Portfolio SIOX Stock Details SIOX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-14,724
Closed -$12K – 2708
2020
Q4 		$12K Buy
+14,724
New +$42.9K ﹤0.01% 1868
2019
Q1 		– Sell
-1,513
Closed -$21K – 1442
2018
Q4 		$21K Sell
1,513
-125
-8% -$1.8K ﹤0.01% 868
2018
Q3 		$10K Buy
1,638
+13
+0.8% +$237 ﹤0.01% 851
2018
Q2 		$17K Buy
1,625
+100
+7% +$1.48K ﹤0.01% 821
2018
Q1 		$22K Sell
1,525
-2,088
-58% -$33.5K ﹤0.01% 756
2017
Q4 		$13K Sell
3,613
-419,262
-99% -$18.8M ﹤0.01% 844
2017
Q3 		$6.13M Buy
+422,875
New +$71.3M 0.29% 67

Other funds holding SIOX

SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Hudson Bay Capital Management
Hudson Bay Capital Management Stamford, Connecticut $29B AUM 30.2% 1-Year Est. Return
CIA
Cladis Investment Advisory Billings, Montana $182M AUM 33.3% 1-Year Est. Return
PM
Prosight Management Dallas, Texas $610M AUM 40.86% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
CC
Clearline Capital New York $1.93B AUM 38.13% 1-Year Est. Return

HAP Trading's SIOX Position: Q3 2017 in Review

HAP Trading sold out of Sio Gene Therapies Inc. Common Stock (SIOX) in Q3 2017, closing a stake of 3,458 shares — an estimated $583K sold.

HAP Trading first reported a position in SIOX in Q1 2017 and held it in 2 quarters. The position peaked at $642K in Q2 2017. 114 funds tracked by Wall St. Rank hold SIOX as of Q3 2017.

  • HAP Trading reported no remaining Sio Gene Therapies Inc. Common Stock position as of Q3 2017 after selling out during the quarter.
  • HAP Trading sold 3,458 Sio Gene Therapies Inc. Common Stock shares in Q3 2017, an estimated $583K.
  • HAP Trading first reported a position in Sio Gene Therapies Inc. Common Stock in Q1 2017 and held it in 2 quarters.
  • HAP Trading's Sio Gene Therapies Inc. Common Stock position peaked at $642K in Q2 2017.
  • 114 funds tracked by Wall St. Rank held Sio Gene Therapies Inc. Common Stock as of Q3 2017.

Based on HAP Trading's 13F filing for Q3 2017, filed 8 Nov 2017.